Desvendando os benefícios dos BCC nos pacientes idosos e com DM2

1- Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, de Magalhães Feitosa AD, et al. Brazilian guidelines of hypertension – 2020. Arq Bras Cardiol. 2021;116(3):516–658.

2- Mancia G, Kreutz R, Brunstr M, Burnier M, Grassi G, Januszewicz A, et al. ESH Guidelines [Internet]. Vol. 41, www.jhypertension.com. 2023.

3- Bakris G, Ali W, Parati G. ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison. Vol. 73, Journal of the American College of Cardiology. Elsevier USA; 2019. p. 3018–26.

4- Angeli F, Verdecchia P, Masnaghetti S, Vaudo G, Reboldi G. Treatment strategies for isolated systolic hypertension in elderly patients. Vol. 21, Expert Opinion on Pharmacotherapy. Taylor and Francis Ltd.; 2020. p. 1713–23.

5- Oliveros E, Patel H, Kyung S, Fugar S, Goldberg A, Madan N, et al. Hypertension in older adults: Assessment, management, and challenges. Vol. 43, Clinical Cardiology. John Wiley and Sons Inc.; 2020. p. 99–107.

6- Jamerson K, et al. “Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients”. The New England Journal of Medicine. 2008. 359(23):2417-2428.